Ahmed Ragab

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 25

Top Venues

RSC advances

Antibiotics (Basel, Switzerland)

Drug development research

Archiv der Pharmazie

Al-Azhar University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Al-Azhar University Mar 07 2012

Egypt

PhD, Lecturer of Organic chemistry :: Faculty of Science - Chemistry Department

Publications

Hamdy Khamees Thabet, Ahmed Ragab, Mohd Imran, Mohamed Hamdy Helal, Saleh Ibrahim Alaqel, Ahmed Alshehri, Abida Ash Mohd, Saleh Saad Alshammari, Yousry A Ammar, Moustafa S Abusaif
Innovation of 6-sulfonamide-2 H -chromene derivatives as antidiabetic agents targeting α-amylase, α-glycosidase, and PPAR-γ inhibitors with in silico molecular docking simulation. RSC advances 14 (22) (2024)
Hamdy Khamees Thabet, Ahmed Ragab, Mohd Imran, Mohamed Hamdy Helal, Saleh Ibrahim Alaqel, Ahmed Alshehri, Abida Ash Mohd, Saleh Saad Alshammari, Yousry A Ammar, Moustafa S Abusaif
Innovation of 6-sulfonamide-2 H -chromene derivatives as antidiabetic agents targeting α-amylase, α-glycosidase, and PPAR-γ inhibitors with in silico molecular docking simulation. RSC advances 14 (22) (2024)
Ahmed Ragab, Mohamed A Salem, Yousry A Ammar, Wael Mahmoud Kamel Aboulthana, Mohamed H Helal, Moustafa S Abusaif
Explore new quinoxaline pharmacophore tethered sulfonamide fragments as in vitro α-glucosidase, α-amylase, and acetylcholinesterase inhibitors with ADMET and molecular modeling simulation. Drug development research 85 (4) (2024)
Youssif M Youssif, Gameel A M Elhagali, Medhat A Zahran, Fatma A Ahmed, Ahmed Ragab
Utilising UPLC-QTOF-MS/MS to determine the phytochemical profile and in vitro cytotoxic potential of Ziziphora capitata L. with molecular docking simulation. Natural product research (2024)
Ashraf S Hassan, Nesrin M Morsy, Wael M Aboulthana, Ahmed Ragab
Exploring novel derivatives of isatin-based Schiff bases as multi-target agents: design, synthesis, in vitro biological evaluation, and in silico ADMET analysis with molecular modeling simulations. RSC advances 13 (14) (2023)
Yousry A Ammar, Ahmed Ragab, M A Migahed, S Al-Sharbasy, Mohamed A Salem, Omnia Karem M Riad, Heba Mohammed Refat M Selim, Gehad A Abd-Elmaksoud, Moustafa S Abusaif
Design, green synthesis, and quorum sensing quenching potential of novel 2-oxo-pyridines containing a thiophene/furan scaffold and targeting a Las R gene on P. aeruginosa . RSC advances 13 (39) (2023)
Ahmed Ragab, Sawsan A Fouad, Yousry A Ammar, Dina S Aboul-Magd, Moustafa S Abusaif
Antibiofilm and Anti-Quorum-Sensing Activities of Novel Pyrazole and Pyrazolo[1,5- a ]pyrimidine Derivatives as Carbonic Anhydrase I and II Inhibitors: Design, Synthesis, Radiosterilization, and Molecular Docking Studies. Antibiotics (Basel, Switzerland) 12 (1) (2023)
Ahmed Ragab, Sawsan A Fouad, Yousry A Ammar, Dina S Aboul-Magd, Moustafa S Abusaif
Antibiofilm and Anti-Quorum-Sensing Activities of Novel Pyrazole and Pyrazolo[1,5- a ]pyrimidine Derivatives as Carbonic Anhydrase I and II Inhibitors: Design, Synthesis, Radiosterilization, and Molecular Docking Studies. Antibiotics (Basel, Switzerland) 12 (1) (2023)
Ashraf S Hassan, Nesrin M Morsy, Wael M Aboulthana, Ahmed Ragab
Exploring novel derivatives of isatin-based Schiff bases as multi-target agents: design, synthesis, in vitro biological evaluation, and in silico ADMET analysis with molecular modeling simulations. RSC advances 13 (14) (2023)
Ahmed Ragab, Sawsan A Fouad, Yousry A Ammar, Dina S Aboul-Magd, Moustafa S Abusaif
Antibiofilm and Anti-Quorum-Sensing Activities of Novel Pyrazole and Pyrazolo[1,5- a ]pyrimidine Derivatives as Carbonic Anhydrase I and II Inhibitors: Design, Synthesis, Radiosterilization, and Molecular Docking Studies. Antibiotics (Basel, Switzerland) 12 (1) (2023)
Reham R Raslan, Yousry A Ammar, Sawsan A Fouad, Sadia A Hessein, Nadia A M Shmiess, Ahmed Ragab
Evaluation of the anti-proliferative activity of 2-oxo-pyridine and 1' H -spiro-pyridine derivatives as a new class of EGFR Wt and VEGFR-2 inhibitors with apoptotic inducers. RSC advances 13 (15) (2023)
Mostafa A Ismail, Moustafa S Abusaif, Mohamed S A El-Gaby, Yousry A Ammar, Ahmed Ragab
A new class of anti-proliferative activity and apoptotic inducer with molecular docking studies for a novel of 1,3-dithiolo[4,5- b ]quinoxaline derivatives hybrid with a sulfonamide moiety. RSC advances 13 (18) (2023)
Mostafa A Ismail, Moustafa S Abusaif, Mohamed S A El-Gaby, Yousry A Ammar, Ahmed Ragab
A new class of anti-proliferative activity and apoptotic inducer with molecular docking studies for a novel of 1,3-dithiolo[4,5- b ]quinoxaline derivatives hybrid with a sulfonamide moiety. RSC advances 13 (18) (2023)
Ahmed Ragab, Seham A Ibrahim, Dina S Aboul-Magd, Mohamed H Baren
One-pot synthesis of pyrazolo[4,3- d ]thiazole derivatives containing α-aminophosphonate as potential Mur A inhibitors against MDR pathogens with radiosterilization and molecular modeling simulation. RSC advances 13 (49) (2023)
Ashraf S Hassan, Nesrin M Morsy, Wael Mahmoud Kamel Aboulthana, Ahmed Ragab
In vitro enzymatic evaluation of some pyrazolo[1,5-a]pyrimidine derivatives: Design, synthesis, antioxidant, anti-diabetic, anti-Alzheimer, and anti-arthritic activities with molecular modeling simulation. Drug development research (2022)
Samar A El-Kalyoubi, Ahmed Ragab, Ola A Abu Ali, Yousry A Ammar, Mohamed G Seadawy, Aya A Saeed, Eman A Fayed
One-Pot Synthesis and Molecular Modeling Studies of New Bioactive Spiro-Oxindoles Based on Uracil Derivatives as SARS-CoV-2 Inhibitors Targeting RNA Polymerase and Spike Glycoprotein. Pharmaceuticals (Basel, Switzerland) 15 (3) (2022)
Ahmed Ragab, Moustafa S Abusaif, Dina S Aboul-Magd, Mohammed M S Wassel, Gameel A M Elhagali, Yousry A Ammar
A new exploration toward adamantane derivatives as potential anti-MDR agents: Design, synthesis, antimicrobial, and radiosterilization activity as potential topoisomerase IV and DNA gyrase inhibitors. Drug development research 83 (6) (2022)
Mahmoud Eldeeb, Eman F Sanad, Ahmed Ragab, Yousry A Ammar, Khaled Mahmoud, Mamdouh M Ali, Nadia M Hamdy
Anticancer Effects with Molecular Docking Confirmation of Newly Synthesized Isatin Sulfonamide Molecular Hybrid Derivatives against Hepatic Cancer Cell Lines. Biomedicines 10 (3) (2022)
Yousry A Ammar, Jehan A Micky, Dina S Aboul-Magd, Sondos M A Abd El-Hafez, Sadia A Hessein, Abeer M Ali, Ahmed Ragab
Development and radiosterilization of new hydrazono-quinoline hybrids as DNA gyrase and topoisomerase IV inhibitors: Antimicrobial and hemolytic activities against uropathogenic isolates with molecular docking study. Chemical biology & drug design (2022)
Radwa Ayman, A M Radwan, Amira M Elmetwally, Yousry A Ammar, Ahmed Ragab
Discovery of novel pyrazole and pyrazolo[1,5-a]pyrimidine derivatives as cyclooxygenase inhibitors (COX-1 and COX-2) using molecular modeling simulation. Archiv der Pharmazie (2022)
Hazem Ali Mohamed, Yousry A Ammar, Gameel A M Elhagali, Hassan A Eyada, Dina S Aboul-Magd, Ahmed Ragab
In Vitro Antimicrobial Evaluation, Single-Point Resistance Study, and Radiosterilization of Novel Pyrazole Incorporating Thiazol-4-one/Thiophene Derivatives as Dual DNA Gyrase and DHFR Inhibitors against MDR Pathogens. ACS omega 7 (6) (2022)
Abdullah Y Alzahrani, Yousry A Ammar, Mohamed A Salem, Mohammed Abu-Elghait, Ahmed Ragab
Design, synthesis, molecular modeling, and antimicrobial potential of novel 3-[(1H-pyrazol-3-yl)imino]indolin-2-one derivatives as DNA gyrase inhibitors. Archiv der Pharmazie (2021)
Essam S A E H Khattab, Ahmed Ragab, Mahmoud A Abol-Ftouh, Ahmed A Elhenawy
Therapeutic strategies for Covid-19 based on molecular docking and dynamic studies to the ACE-2 receptors, Furin, and viral spike proteins. Journal of biomolecular structure & dynamics (2021)
Ahmed Ragab, Sawsan A Fouad, Ola A Abu Ali, Entsar M Ahmed, Abeer M Ali, Ahmed A Askar, Yousry A Ammar
Sulfaguanidine Hybrid with Some New Pyridine-2-One Derivatives: Design, Synthesis, and Antimicrobial Activity against Multidrug-Resistant Bacteria as Dual DNA Gyrase and DHFR Inhibitors. Antibiotics (Basel, Switzerland) 10 (2) (2021)
Ashraf S Hassan, Ahmed A Askar, Ahmed M Naglah, Abdulrahman A Al-Mehizia, Ahmed Ragab
Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity. Molecules (Basel, Switzerland) 25 (11) (2020)

Ahmed Ragab.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ahmed Ragab